Cuprous Iodide

We are Cuprous Iodide CAS:1335-23-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Other name:

Copper(I) Iodide
Cuprous Iodide
 

CAS No.: 1335-23-5

Molecular Formula: 

CuI

Molecular Weight: 190.45
 

Characters: White crystal or offwhite powder, will turn brownish yellow when exposed to light; insoluble in water and ethanol. soluble in concentrated sulfuric acid and Hcl, also soluble in ammonia water, potassium iodide. Relative density: 5.63, m.p.: 605℃, b.p.: 1290℃

Specifications:

Cuprous Iodide A.R. C.P. Pharmaceutical grade
Item Spec. Spec. Spec.
Assay(asCuI)% ≥99.5 ≥99.0 ≥99.0
Insol. in Hcl % ≤0.01 ≤0.02 ≤0.05
Sulphates(asSO4)% ≤0.01 ≤0.02 ≤0.02
Alkali metals and alkaline-earth metals(asSO4)% ≤0.1 ≤0.2 ≤0.2
Fe% ≤0.003 ≤0.005 ≤0.01

Product Usage: It is used in the manufacture of auxiliaries for chinlon filature and pharmaceutical intermediate; as catalyst for organic synthesis.

Packaging: 25Kg cardboard drum, lined with double-layer plastic bag

Storage Precautions: Stored in cool, dry and draughty warehouse, sealed tightly, kept away from heat source and fire; can transported together with combustibles and oxidants in seperation conditions, handle with care.

Cuprous Iodide


Related News: Remogliflozin is economical than other similar agents currently available in sodium glucose co-transporter-2 (SGLT2) inhibitors class, which shall help for its better access among middle and low socio-economic strata of the society, he added.2,3,5,6-Tetrafluoro-4-(Methoxymethyl) benzyl alcohol It is estimated that the size of China’s CMO market has reached about USD 5 billion. With the implementation and further implementation of the MAH system (the core is to separate drug marketing authorization from drug production authorization) in China, it is expected to promote the outbreak of the domestic drug CMO industry. It will grow at a rate of 20% to 30%, of which patented APIs occupy a larger proportion.1H-Imidazol-1-ylacetonitrile CAS:98873-55-3 It is estimated that the size of China’s CMO market has reached about USD 5 billion. With the implementation and further implementation of the MAH system (the core is to separate drug marketing authorization from drug production authorization) in China, it is expected to promote the outbreak of the domestic drug CMO industry. It will grow at a rate of 20% to 30%, of which patented APIs occupy a larger proportion.epiclorhidrina CAS:106-89-8 At the same time, due to the increase in production costs and environmental protection cost pressures in Europe and the United States, as well as the improvement of process technology, production quality, and registration and certification capabilities of China’s bulk drug manufacturers, bulk drug companies have accelerated their transfer to China, and the bulk drug industry in China has produced Scale continues to increase.At the same time, due to the increase in production costs and environmental protection cost pressures in Europe and the United States, as well as the improvement of process technology, production quality, and registration and certification capabilities of China’s bulk drug manufacturers, bulk drug companies have accelerated their transfer to China, and the bulk drug industry in China has produced Scale continues to increase.

Related Products
Product Name
Tris(trimethylsilyl) borate Cas:4325-85-3 View Details
Antioxidant 8330 View Details
Sodium Nitrate View Details
2-Bromo-6-nitroaniline manufacturer Difluoromethanesulfonyl chloride Cas:1512-30-7 manufacturer 6-Fluoro-1-methyl-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid manufacturer (2E,4E)-2,4-Octadienal manufacturer Asafetida manufacturer